Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation for the periodontal tissue defects - Platelet rich plasma transplantation for the periodontal tissue defects

Juntendo University0 sites2 target enrollmentMarch 17, 2019

Overview

No summary available.

Registry

who.int

Start Date

March 17, 2019

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•Patient MUST NOT: 1\) Can not be measured clinical attachment level of experimental tooth. 2\) Have a history of Complicate malignant tumor. 3\) Suspected of oral malignant tumor or precancerous lesion. 4\) Need to undergo the treatment, such as surgical treatment, restorative treatment or root canal treatment, at the experimental tooth within 36 weeks after transplant. 5\) Pregnancy, during breastfeeding, or possibility of pregnancy. 6\) Persons who suffer from disorders of kidney, liver or blood 7\) Have disease of kidney, liver and/or blood. 8\) Have active infectious diseases. 9\) Alcoholism or Drug dependence. 10\) Mental or consciousness disorder. 11\) HCV antibody, HBs antigen, ATLA virus antibody or HIV antibody positive person. 12\) Smoke more than 10 pieces per day. 13\) Have anti\-coagulant or anti\-platelet medications, or have a bleeding disorders. 14\) Other,the investigator believes makes him/her unsuitable for participation in the clinical study.